Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.
Syngene’s offers an end-to-end platform to deliver integrated and standalone services for small molecules across the Development continuum.
Syngene offers integrated and standalone services across the drug discovery continuum from Target Identification to IND enabling.
Syngene, with its comprehensive suite of DMPK profiling assays, can help you achieve a high rate of success with your clinical candidates across drug modalities.
Syngene’s Target Identification and Validation services combine data, informatics, and knowledge about biological target assays for holistic target assessment and risk mitigation in drug discovery.
Syngene’s Chemistry process research lab acts as a bridge between drug discovery and development when faster delivery of chemical compounds is required – mg to kg.
Syngene has one of the largest Analytical facilities in Asia. The facility supports small molecules and biologics programs from early development to CMC filing and commercialization.
Syngene’s Sterile Fill-Finish facility is custom-built to meet market demand for clinical supply of sterile drug products having short development timelines.
Synene has developed more than 100 assays for conducting BA/BE studies across small molecules and biologics.
One of the largest Stability facilities in Asia, Syngene supports both small molecules and biologics from early development to CMC
Syngene has full value-chain Process Research and Development (PRD) capabilities for NCEs and advanced intermediates.
Syngene supports early-phase to late-phase clinical trials required for drug development programs across a wide range of therapeutic areas.
Syngene offers biologics development and manufacturing solutions across mammalian and microbial systems.
Syngene offers the full range of IND-enabling Exploratory and GLP Tox studies for small molecules and biologics.
Syngene’s Center of Excellence for Nitrosamine impurity testing supports formulation requirements for small molecule APIs, key sourcing materials, and intermediates.
Syngene offers end-to-end and integrated solutions for PROTACs ranging from early proof-of-concept studies to identifying a development candidate.
Syngene has a well-defined system that delivers across all aspects of Supply Chain Management, ranging from planning and inventory to sourcing, procurement, logistics, performance, safety, and compliance.
Syngene’s services encompass Therapeutic oligonucleotides, Diagnostic Oligonucleotides, Enzymatic synthesis and analytical services.
© 2023. Syngene International Limited